UHS
Universal Health Services
Health Care · Health Care Facilities · US
✓ ETHICAL PASS
NARROW MOAT
HIGH
Data Confidence: 100.0%
Key Metrics
How this company measures up on the fundamentals that matter
Market Cap
$10.2B
Total market value of the company
7.05
Very cheap relative to earnings
6.65
Based on estimated future earnings — lower means cheaper
Rev Growth
+9.6%
Year-over-year revenue change
Profit Margin
8.6%
How much profit the company keeps from each dollar of revenue
21.4%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$223.31
+54% from current price — median analyst estimate
Recommendation
BUY
Consensus view from 16 analysts covering this stock
About Universal Health Services
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
https://uhs.com
Country: United States Employees: 101,500 Industry: Medical Care Facilities
Ethical Screening
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
33.3% PASS
Debt must be below 33% of total assets
Cash Ratio
0.0% PASS
Interest-bearing cash below 33% of assets
Receivables
17.6% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Valuation
$304.96
What our model estimates this business is worth per share
52.4%
Deep discount to fair value — significant undervaluation
Rating
OPPORTUNITY
Overall assessment combining ethics, valuation, and quality
98.6th
Ranks in the top 1% of our 13,571 screened universe
Trading at $169 against a fair value of $305, a 45% discount. Passes all ethical screens. Ranks better than 96% of screened stocks.
Quantitative Intelligence
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
DISTRIBUTION
Smart money appears to be selling into strength — caution
0.010
Positive but modest risk-adjusted returns
0.0010
Marginal edge — very small allocation suggested
-0.143
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-5.1%
Historical annualised return based on price data
-35.7%
Largest peak-to-trough decline — the worst it has been
BEAR
Statistical model detects bearish conditions
Days in State
19
How long the current regime has persisted — longer means more stable
Market Data
Trading characteristics and market positioning
1.13
Moves slightly more than the broader market
52W High
$246.33
41% below the year high
52W Low
$152.33
-5% above the year low
Avg Volume
829,243
Average daily shares traded — higher means easier to buy and sell
3.9
Days it would take all short sellers to cover — higher means more crowded
Short % Float
6.5%
Moderate short interest
0.5%
Annual dividend as a percentage of the share price
$23.95
Earnings per share over the last 12 months
Financial Health
Balance sheet strength and cash generation — the foundation of long-term value
0.67
Moderate leverage — manageable
1.08
Adequate but worth monitoring
Quick Ratio
0.88
Like current ratio but excludes inventory — stricter test
Gross Margin
44.2%
Revenue left after cost of goods — higher means pricing power
Operating Margin
11.2%
Profit from core operations before interest and tax
$651M
Positive — the business generates more cash than it spends
Revenue (TTM)
$17.8B
Total revenue over the last 12 months
Net Income
$1.5B
Profitable — the bottom line is positive
Recent Insider Activity
SEC Form 4 filings — what company insiders are buying and selling
45
NEUTRAL
Mixed insider activity. 0 purchases and 0 sales in the last 90 days — no clear directional signal. Political selling noted.
| Date |
Insider |
Title |
Type |
Shares |
Value |
| 2026-03-26 |
MILLER ALAN B |
Officer, Director and Beneficial Owner |
|
14,153 |
— |
| 2026-03-26 |
MILLER MARC D |
Chief Executive Officer |
|
29,715 |
— |
| 2026-03-26 |
PETERSON MATTHEW JAY |
Officer |
|
5,627 |
— |
| 2026-03-26 |
SIM EDWARD H. |
Officer |
|
6,404 |
— |
| 2026-03-26 |
FILTON STEVEN G. |
Chief Financial Officer |
|
6,850 |
— |
| 2026-03-13 |
SUSSMAN ELLIOT J |
Director |
|
674 |
$128,099 |
| 2026-03-13 |
SUSSMAN ELLIOT J |
Director |
|
2,500 |
$347,000 |
| 2026-03-12 |
MILLER MARC D |
Chief Executive Officer |
|
100,425 |
$14,638,889 |
| 2026-03-12 |
SINGER MARIA RUDERMAN |
Director |
|
2,500 |
$347,000 |
| 2026-03-12 |
FILTON STEVEN G. |
Chief Financial Officer |
|
83,237 |
$12,164,529 |
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Political Trading Activity
Congressional trading disclosures involving this instrument
| Date |
Politician |
Party |
Type |
Amount |
| 2026-04-13 |
Ro Khanna |
Democrat |
Sale |
1K–15K |
Source: Congressional disclosure filings. View all political trades at
Insider Intelligence
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15